Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

Código QR

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

Timothy L Comstock1, Paul M Karpecki2, Timothy W Morris3, Jin-Zhong Zhang41Global Medical Affairs, Pharmaceuticals, Bausch and Lomb, Inc., Rochester, NY, USA; 2Koffler Vision Group, Lexington, KY, USA; 3Research and Development Microbiology and Sterilization Sciences, Bausch and Lomb, Inc., Rocheste...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Timothy L Comstock, Paul M Karpecki, Timothy W Morris, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/558707f1c679417aa2490cd37df17be9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
por: Silverstein BE, et al.
Publicado: (2012)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
por: Morris TW, et al.
Publicado: (2011)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
por: Haas W, et al.
Publicado: (2011)

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
por: Bucci FA Jr, et al.
Publicado: (2015)

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration
por: Gail Torkildsen, et al.
Publicado: (2010)

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
por: Cervantes LJ, et al.
Publicado: (2011)

Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones
por: Haas W, et al.
Publicado: (2013)

Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin
por: Rudolph S Wagner, et al.
Publicado: (2010)

Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6%
por: Blondeau JM, et al.
Publicado: (2021)

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
por: Patricia B Williams, et al.
Publicado: (2010)

Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
por: Timothy L Comstock, et al.
Publicado: (2011)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Eiichi Uchio
Publicado: (2008)

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
por: Jeremy B Wingard, et al.
Publicado: (2011)

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
por: Bergmann MT, et al.
Publicado: (2014)

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness
por: Bremond-Gignac D, et al.
Publicado: (2015)

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
por: Nielsen SA, et al.
Publicado: (2013)

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
por: Nielsen SA, et al.
Publicado: (2013)

Acute hemorrhagic conjunctivitis: anti-coxsackievirus A24 variant secretory immunoglobulin A in acute and convalescent tear
por: Langford MP, et al.
Publicado: (2015)

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
por: Chigbu DI, et al.
Publicado: (2015)

Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
por: Samuel K Houston, et al.
Publicado: (2011)

Ligneous conjunctivitis in a patient with Crohn&prime;s disease
por: Graciana Fuentes-P&aacute;ez, et al.
Publicado: (2008)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
por: Darlene Miller
Publicado: (2008)

Fluoroquinolones compared to 1% azithromycin in DuraSite&reg; for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
por: Steven J Lichtenstein, et al.
Publicado: (2008)

Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report
por: DaCosta J
Publicado: (2012)

Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study
por: Malhotra R, et al.
Publicado: (2012)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: R Prince Davis, et al.
Publicado: (2010)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: A Jayaprakash Patil, et al.
Publicado: (2010)

Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma
por: Lejla Mutapcic Vajzovic, et al.
Publicado: (2011)

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis
por: Ludimila L Cavalcante, et al.
Publicado: (2010)

Use of nepafenac (Nevanac&reg;) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
por: Eric Chen, et al.
Publicado: (2010)

Virological and epidemiological analysis of coxsackievirus A24 variant epidemic of acute hemorrhagic conjunctivitis in Okinawa, Japan, in 2011
por: Harada K, et al.
Publicado: (2015)

Cecocentral scotoma as the initial manifestation of subacute bacterial endocarditis
por: Danielle Savitsky Strauss, et al.
Publicado: (2011)

The epidemiology and treatment of conjunctivitis at Urgent Care Centres in Israel
por: Gordon-Shaag A, et al.
Publicado: (2019)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
por: Arthur B Epstein, et al.
Publicado: (2009)

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen G, et al.
Publicado: (2015)

Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
por: Awara A, et al.
Publicado: (2020)

Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
por: Gomes PJ, et al.
Publicado: (2013)

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
por: Ciolino JB, et al.
Publicado: (2015)

A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management
por: Yeu E, et al.
Publicado: (2020)

Bilateral endogenous Candida albicans subretinal abscess with suspected mixed bacterial infection
por: Arai Y, et al.
Publicado: (2014)